Asset Management One’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Asset Management One’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-55,763	Closed	-$7.25M	–	1280
2016 Q3	$7.25M	Sell	55,763 -14,395	-21%	-$1.38M	0.11%	212
2016 Q2	$6.54M	Sell	70,158 -28,158	-29%	-$2.37M	0.1%	225
2016 Q1	$6.97M	Buy	98,316 +17,685	+22%	+$970K	0.1%	213
2015 Q4	$5.6M	Buy	80,631 +13,235	+20%	+$1.08M	0.08%	283
2015 Q3	$5.98M	Sell	67,396 -5,682	-8%	-$632K	0.09%	278
2015 Q2	$8.72M	Sell	73,078 -7,571	-9%	-$859K	0.12%	214
2015 Q1	$7.13M	Buy	80,649 +10,421	+15%	+$846K	0.09%	293
2014 Q4	$4.72M	Buy	70,228 +21,291	+44%	+$1.56M	0.06%	403
2014 Q3	$4.19M	Buy	+48,937	New	+$4.33M	0.06%	395

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Asset Management One's GWPH Position: Q4 2016 in Review

Asset Management One sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2016, closing a stake of 55,763 shares — an estimated $7.25M sold.

Asset Management One first reported a position in GWPH in Q3 2014 and held it in 9 quarters. The position peaked at $8.72M in Q2 2015. 164 funds tracked by Wall St. Rank hold GWPH as of Q4 2016.

Asset Management One reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 55,763 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2016, an estimated $7.25M.
Asset Management One first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 9 quarters.
Asset Management One's GW Pharmaceuticals Plc American Depositary Shares position peaked at $8.72M in Q2 2015.
164 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.